Sinae Citrate Tofacitinib fabrica, supplementum, Factory

Jiangsu Run'an Pharmaceutical Co, Ltd., subsidiaria omnino possessa de Jiangsu Chiatai Qingjiang Pharmaceutical Co, Ltd., modernus summus tech pharmaceuticus societas specialis in R&D, productionis et venditio fertilitatis ordinandae medicinae et varietatis APIs. Project constructionem mense Novembri 2018 incepit, LIX mu aream obtegens, cum tota obsidione 160 decies Yuan et tota area aedificium 25000 quadratum metrorum.

Praecipuum activum medicamentum pharmaceuticum (API) producta: Hydrochloride Gemcitabinum, Celecoxib, bromhexinum hydrochloridum, Iguratimod, Apremilast, Citrate Tofacitinib, Crisaborole, Urapidil Hydrochloride, Sugammadex Natri, Garlicin, Dexmedetomidine Hydrochloride, Rocuronium Bromidum, Finerenone, etc. elit mundi genus facti et productorum gignentium opificem per constantem emendationem et innovationem in technologiarum, et occasiones praeclarum negotium praebent sodalibus nostris per orbem terrarum. Munus nostrum ad praestantes operas emptores nobis permisit solidas relationes cum sociis nostris toto orbe includere.

View as  
 
CAS#540737-29-9

CAS#540737-29-9

CAS#540737-29-9 est medicamento arthritis rheumatoidei, arthritis psoriatica medicamentum, spondylitis medicamentum ankylosingum, polyarticularis utique pharmacum arthritis juvenile idiopathicum, medicamentum ulcerativae colitis.

Lege plusMitte Inquisitionem
(3R,4R) -4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino) propanetricarboxylate

(3R,4R) -4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino) propanetricarboxylate

(3R,4R) -4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino) propanetricarboxylatum est medicamento arthritis rheumatoidei, medicamento arthritis psoriatic, spondylitis medicamento ankylosing, polyarticularis utique arthritis juvenilis idiopathica medicamento, medicamento ulcerativa colitis.

Lege plusMitte Inquisitionem
CAS NO.540737-29-9

CAS NO.540737-29-9

CAS NO.540737-29-9 medicamentum arthritis rheumatoidei, arthritis psoriaticum medicamentum, spondylitis medicamentum ankylosing, polyarticularis utique pharmacum arthritis juvenile idiopathicum, medicamentum ulcerativum.

Lege plusMitte Inquisitionem
CAS 540737-29-9

CAS 540737-29-9

CAS 540737-29-9 est medicamentum arthritis rheumatoidis, medicamentum arthritis psoriaticum, medicamentum spondylitis ankylosing, polyarticularis utique pharmacum arthritis juvenilis idiopathica, medicamento ulcerativa.

Lege plusMitte Inquisitionem
540737-29-9

540737-29-9

540737-29-9 est medicamento arthritis rheumatoidei, medicamento arthritis psoriaticae, medicamento ankylosing spondylitis, polyarticularis cursus juvenilis arthritis idiopathica medicamento, medicamento ulcerativi colitis.

Lege plusMitte Inquisitionem
Tofacitinib Citrate API

Tofacitinib Citrate API

Tofacitinib Citrate API est medicamento arthritis rheumatoidei, arthritis psoriatic medicamentum, spondylitis medicamento ankylosing, polyarticularis utique pharmacum arthritis juvenile idiopathicum, medicamentum ulcerativi colitis.

Lege plusMitte Inquisitionem
<1>
Quiescere potes ex officina nostra emere Citrate Tofacitinib in Sinis. Pharmaceutical Run'an professionalis Sinarum Citrate Tofacitinib fabrica et supplementum, qualitas products alta praebere possumus. Grata res emendas ex officina nostra.
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept